Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
(OP:
ESAIY
)
9.870
-0.230 (-2.28%)
Streaming Delayed Price
Updated: 3:59 PM EDT, Jun 14, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
88,682
Open
9.850
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
10.10
Today's Range
9.845 - 10.00
52wk Range
9.310 - 18.87
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Eli Lilly's Donanemab Gains Favorable FDA Advisory Verdict, Boosting Stock Potential, Says BofA Analyst
June 11, 2024
Eli Lilly's donanemab for Alzheimer's disease garners positive FDA committee verdict, prompting analyst's bullish outlook amid comparisons to Biogen's Leqembi.
Via
Benzinga
Exposures
Product Safety
Eli Lilly Drags Alzheimer's Stocks Prothena, Eisai Lower Despite FDA Win
June 11, 2024
An FDA panel unanimously backed Eli Lilly's Alzheimer's drug, but shares of Lilly and its rivals fell Tuesday.
Via
Investor's Business Daily
Exposures
Product Safety
Performance
YTD
-20.11%
-20.11%
1 Month
-11.48%
-11.48%
3 Month
-6.36%
-6.36%
6 Month
-21.35%
-21.35%
1 Year
-41.76%
-41.76%
More News
Read More
Eli Lilly Rises Again, As FDA Panel Mulls Biogen-Rivaling Alzheimer's Drug
June 10, 2024
Via
Investor's Business Daily
Exposures
Product Safety
The 3 Most Undervalued Pharma Stocks to Buy in June 2024
June 06, 2024
Via
InvestorPlace
Topics
Economy
Exposures
Economy
Biogen Stock Continues Its 20% Sprint On A Twist In Alzheimer's Treatment
May 15, 2024
Via
Investor's Business Daily
Current Analysis: Eisai Co Ltd (ESAIY)
July 16, 2023
Via
Talk Markets
Two Notable Biogen Drugs Walloped Sales Forecasts. Will It Be Enough To Reverse Biogen Stock's Decline?
April 24, 2024
Via
Investor's Business Daily
Topics
Earnings
Exposures
Financial
3 Stocks Wall Street Is Ignoring (But You Shouldn’t): April Edition
April 11, 2024
Via
InvestorPlace
Race To Treat Alzheimer's Disease Is Heating Up Despite Eli Lilly's Setback
March 28, 2024
Via
Investor's Business Daily
Exposures
Product Safety
3 Millionaire-Maker Stocks to Buy While the Gettin’ Is Good
February 12, 2024
Via
InvestorPlace
Week In Review: I-Mab Morphs Into US-Only Company; Sells China Assets For $80 Million
February 11, 2024
Via
Talk Markets
Brain Disease Cures: 3 Neuroscience Stocks Targeting Revolutionary Breakthroughs
January 23, 2024
Via
InvestorPlace
Eli Lilly, Crispr, Biogen Lead Pharma And Biotech Stocks To Great Expectations In 2024
January 05, 2024
Via
Investor's Business Daily
3 Aging Population Stocks to Profit from the Boomer Generation
December 21, 2023
Via
InvestorPlace
Alzheimer's Disease Vaccines: Promising Developments, Renewed Enthusiasm From Biogen, Eli Lilly And Others
November 21, 2023
Via
Benzinga
Quest For Alzheimer's Cure: Big Biotech Breakthroughs, But The Race Is Just Beginning
November 17, 2023
Via
Investor's Business Daily
3 Biotech Moonshots to Bet on the Future of Health
November 06, 2023
Via
InvestorPlace
Topics
Intellectual Property
Exposures
Intellectual Property
The 3 Best Biotech Stocks to Buy Now: September 2023
September 04, 2023
Via
InvestorPlace
3 Millionaire-Maker Biotech Stocks to Buy Before the Window Closes
July 30, 2023
Via
InvestorPlace
All Eyes On Biogen's Alzheimer's Drug, A Big Potential Payday, Ahead Of Earnings
July 24, 2023
Via
Investor's Business Daily
Stock Futures Dip As Traders Eye Friday Jobs Report: Analyst Says Q3 Returns Hinge More On This Catalyst Than Fed Move
July 07, 2023
Via
Benzinga
Biogen's Make-Or-Break Moment Is Here In Alzheimer's Treatment
July 06, 2023
Via
Investor's Business Daily
Biogen Stock Halted As It Faces Make-Or-Break Moment For Alzheimer's Treatment
June 09, 2023
Via
Investor's Business Daily
Biogen Rises As 'Relatively Benign' FDA Documents Suggest An Alzheimer's Approval Is Near
June 07, 2023
Via
Investor's Business Daily
Biogen Hits Buy Zone On A Fresh Win In Alzheimer's Disease; Eli Lilly, Eisai Shares Jump
June 01, 2023
Via
Investor's Business Daily
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.